+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Device Analytical Testing Outsourcing Market by Device Type , Service , by End-use , 2022 - 2032

  • PDF Icon

    Report

  • November 2022
  • Region: Global
  • Transparency Market Research
  • ID: 5710021

Medical Device Analytical Testing Outsourcing Market - Scope of Report

This report on the global medical device analytical testing outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global medical device analytical testing outsourcing market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical device analytical testing outsourcing market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the medical device analytical testing outsourcing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical device analytical testing outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global medical device analytical testing outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical device analytical testing outsourcing market.

The report delves into the competitive landscape of the global medical device analytical testing outsourcing market. Key players operating in the global medical device analytical testing outsourcing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global medical device analytical testing outsourcing market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market medical device analytical testing outsourcing.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:

  • WorldWideScience.org
  • Elsevier, Inc
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

The publisher conducts primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd
  • IBA Worldwide
  • Mevion Medical Systems, Inc
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with the publisher's “Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Device Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Device Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Device Type, 2022-2032
5.3.1. Reprocessed Devices
5.3.1.1. Hospital
5.3.1.2. Others
5.3.1.3. SNP Analysis
5.3.1.4. Mutational Analysis
5.3.1.5. Microarray Analysis
5.3.1.6. RNA Interference
5.3.2. Other Device Types
5.4. Y-o-Y Growth Trend Analysis By Device Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Device Type, 2022-2032
6. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Service
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Service, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service, 2022-2032
6.3.1. Extractable and Leachable
6.3.2. Material Characterization
6.3.3. Physical Testing
6.3.4. Bioburden Testing
6.3.5. Sterility Testing
6.3.6. Other Services
6.4. Y-o-Y Growth Trend Analysis By Service, 2017-2021
6.5. Absolute $ Opportunity Analysis By Service, 2022-2032
7. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Therapeutic Areas
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Therapeutic Areas, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapeutic Areas, 2022-2032
7.3.1. Cardiology
7.3.2. Diagnostic Imaging
7.3.3. Orthopedic
7.3.4. IVD
7.3.5. Ophthalmic
7.3.6. General & Plastic Surgery
7.3.7. Drug Delivery
7.3.8. Endoscopy
7.3.9. Dental
7.3.10. Diabetes Care
7.3.11. Other Therapeutic Areass
7.4. Y-o-Y Growth Trend Analysis By Therapeutic Areas, 2017-2021
7.5. Absolute $ Opportunity Analysis By Therapeutic Areas, 2022-2032
8. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2022-2032
8.3.1. Hospital
8.3.2. Other End-uses
8.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021
8.5. Absolute $ Opportunity Analysis By End-use, 2022-2032
9. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Device Type
10.2.3. By Service
10.2.4. By Therapeutic Areas
10.2.5. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Device Type
10.3.3. By Service
10.3.4. By Therapeutic Areas
10.3.5. By End-use
10.4. Key Takeaways
11. Latin America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Device Type
11.2.3. By Service
11.2.4. By Therapeutic Areas
11.2.5. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Device Type
11.3.3. By Service
11.3.4. By Therapeutic Areas
11.3.5. By End-use
11.4. Key Takeaways
12. Europe Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. U.K.
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Russia
12.2.1.7. Rest of Europe
12.2.2. By Device Type
12.2.3. By Service
12.2.4. By Therapeutic Areas
12.2.5. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Device Type
12.3.3. By Service
12.3.4. By Therapeutic Areas
12.3.5. By End-use
12.4. Key Takeaways
13. Asia Pacific Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. India
13.2.1.4. South Korea
13.2.1.5. Australia
13.2.1.6. Rest of APAC
13.2.2. By Device Type
13.2.3. By Service
13.2.4. By Therapeutic Areas
13.2.5. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Device Type
13.3.3. By Service
13.3.4. By Therapeutic Areas
13.3.5. By End-use
13.4. Key Takeaways
14. Middle East and Africa Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. Saudi Arabia
14.2.1.3. UAE
14.2.1.4. Israel
14.2.1.5. Rest of MEA
14.2.2. By Device Type
14.2.3. By Service
14.2.4. By Therapeutic Areas
14.2.5. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Device Type
14.3.3. By Service
14.3.4. By Therapeutic Areas
14.3.5. By End-use
14.4. Key Takeaways
15. Key Countries Medical Device Analytical Testing Outsourcing Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Device Type
15.1.2.2. By Service
15.1.2.3. By Therapeutic Areas
15.1.2.4. By End-use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Device Type
15.2.2.2. By Service
15.2.2.3. By Therapeutic Areas
15.2.2.4. By End-use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Device Type
15.3.2.2. By Service
15.3.2.3. By Therapeutic Areas
15.3.2.4. By End-use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Device Type
15.4.2.2. By Service
15.4.2.3. By Therapeutic Areas
15.4.2.4. By End-use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Device Type
15.5.2.2. By Service
15.5.2.3. By Therapeutic Areas
15.5.2.4. By End-use
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Device Type
15.6.2.2. By Service
15.6.2.3. By Therapeutic Areas
15.6.2.4. By End-use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Device Type
15.7.2.2. By Service
15.7.2.3. By Therapeutic Areas
15.7.2.4. By End-use
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Device Type
15.8.2.2. By Service
15.8.2.3. By Therapeutic Areas
15.8.2.4. By End-use
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Device Type
15.9.2.2. By Service
15.9.2.3. By Therapeutic Areas
15.9.2.4. By End-use
15.10. Russia
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Device Type
15.10.2.2. By Service
15.10.2.3. By Therapeutic Areas
15.10.2.4. By End-use
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Device Type
15.11.2.2. By Service
15.11.2.3. By Therapeutic Areas
15.11.2.4. By End-use
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Device Type
15.12.2.2. By Service
15.12.2.3. By Therapeutic Areas
15.12.2.4. By End-use
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Device Type
15.13.2.2. By Service
15.13.2.3. By Therapeutic Areas
15.13.2.4. By End-use
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Device Type
15.14.2.2. By Service
15.14.2.3. By Therapeutic Areas
15.14.2.4. By End-use
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Device Type
15.15.2.2. By Service
15.15.2.3. By Therapeutic Areas
15.15.2.4. By End-use
15.16. South Africa
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Device Type
15.16.2.2. By Service
15.16.2.3. By Therapeutic Areas
15.16.2.4. By End-use
15.17. Saudi Arabia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Device Type
15.17.2.2. By Service
15.17.2.3. By Therapeutic Areas
15.17.2.4. By End-use
15.18. UAE
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Device Type
15.18.2.2. By Service
15.18.2.3. By Therapeutic Areas
15.18.2.4. By End-use
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Device Type
15.19.2.2. By Service
15.19.2.3. By Therapeutic Areas
15.19.2.4. By End-use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Device Type
16.3.3. By Service
16.3.4. By Therapeutic Areas
16.3.5. By End-use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. SGS SA
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Toxikon, Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Eurofins Scientific
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Pace Analytical Services LLC
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Intertek Group plc
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Wuxi AppTec
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Envigo
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Charles River Laboratories
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Medical Device Testing Services
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
18. Assumptions & Acronyms Used19. Research Methodology

Companies Mentioned

A selection of companies mentioned in this report includes:

  • SGS SA
  • Toxikon, Inc.
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group plc
  • Wuxi AppTec
  • Envigo
  • Charles River Laboratories
  • Medical Device Testing Services